Sep 11, 2023 / 05:35PM GMT
Unidentified Analyst -
All right. Why don't we kick this off? So it's Patrick on the U.S. Medtech team.
I got the exciting disclaimers for you guys. So for the disclosures, please go to Morgan Stanley research disclosures website at morganstanley.com/researchdisclosures. I'm sure all will be going there. If you have any questions, feel free to reach out to your sales rep. So I'll say there bye-bye.
So massive thank you to Tandem. We've got John Sheridan, obviously, and Leigh Vosseller here, agreed to join us as CEO and CFO. An open fireside chat should be a lot of fun. So thank you for joining us.
John F. Sheridan - Tandem Diabetes Care, Inc. - President, CEO & Director
Nice to be here, Patrick.
Questions and Answers:
Unidentified Analyst -Thank you. Maybe as an opener, just to sort of set the scene, what do you feel gives Tandem its competitive edge in the pump market overall? And how do you feel like what's the DNA of the company that really gives the edge to Tandem?
John F. Sheridan<
Trustpilot
